The Pharma Data

DECEMBER 11, 2020

Centers for Disease Control and Prevention. Third of Americans live where hospitals are short on ICU beds. In a sign that the coronavirus pandemic is entering its most dire stage yet, new federal data shows that more than one-third of Americans now live in areas where hospitals are critically short of intensive care unit (ICU) beds.

Vaccine 52

Vaccine FDA Hospitals Doctors 52

Drug Discovery World

APRIL 14, 2023

He is being recognised for his revolutionary contributions to developing the first gene-edited cell-based therapy for cancer that involves the genetic re-engineering of a patient’s own T cells to combat their disease, and for demonstrating that adoptive T-cell therapy can induce remission and in some cases cure patients with advanced cancer.

Clinical Trials 130

Clinical Trials Research Science Clinical Research 130

The Pharma Data

JULY 21, 2021

Bayer also issued a news release earlier today announcing the EC approval. Food and Drug Administration (FDA) approved VERQUVO in the U.S. The approval of VERQUVO in the EU will provide doctors, health care professionals and patients with an important treatment option to complement currently available heart failure therapies.”.

Treatment 52

Treatment Production Hospitals FDA Approval 52

The Pharma Data

MAY 16, 2021

Description: I’ve been a researcher for over 15 years at one of the biggest hospitals in Cleveland, Ohio. Every capsule is made here, in the USA, in our FDA approved and GMP certified facility, under sterile, strict and precise standards. Products are not intended to diagnose, treat, cure or prevent any disease.

Production 52

Production Nurses FDA Approval Packaging 52

The Pharma Data

JANUARY 26, 2021

“The death toll from COVID-19 continues to rise around the world and hospitalizations, particularly in the U.S., These data further support our belief that bamlanivimab and etesevimab together have the potential to be an important treatment that significantly reduces hospitalizations and death in high-risk COVID-19 patients.

Hospitals 52

Hospitals Treatment Long-Term Care Facilities Trials 52

Codon

JULY 14, 2024

In 1940, Charles Drew—the first African-American researcher to earn a doctor of medical science degree at Columbia University—developed an ingenious method for separating and storing plasma , the liquid part of blood that contains essential proteins that promote clotting and regulate blood pressure. In the U.S.,

Production 133

Production Clinical Trials Trials Therapies 133

The Pharma Data

JUNE 26, 2021

If approved, XARELTO ® will be the first and only oral Factor Xa inhibitor indicated in the U.S. There are currently no FDA-approved anticoagulation therapies for pediatric patients with congenital heart disease who have undergone the Fontan procedure, a surgical procedure that redirects blood flow from the lower body to the lungs.

Doctors 52

Doctors Hospitals Clinical Trials Treatment 52

The Pharma Data

NOVEMBER 4, 2020

Previously they had recommended use of VASCEPA for treating patients with established cardiovascular disease. Amarin is optimistic that the worst period of impact from COVID-19 on the levels of patients seeking ordinary course doctor visits and lab tests may be behind it. Thero, president and chief executive officer. “We

Production 40

Production FDA Trials Licensing 40

The Pharma Data

OCTOBER 24, 2020

The country could soon be facing its worst stretch of the pandemic, with some hospitals in the West and Midwest already overwhelmed and death counts beginning to rise, the Post reported. Already, hospitals are reporting shortfalls of basic drugs needed to treat COVID-19 infections. Remdesivir gets full FDA approval to treat COVID-19.

Hospitals 52

Hospitals Virus FDA Government 52

The Pharma Data

OCTOBER 25, 2020

Real-world effectiveness data on Oxbryta ® (voxelotor) in the treatment of sickle cell disease featured as oral presentation. Two abstracts have been accepted for presentation, including real-world effectiveness data of Oxbryta ® (voxelotor) tablets in the treatment of sickle cell disease (SCD). FDA approval. 26-31, 2020.

Treatment 52

Treatment Disease FDA FDA Approval 52

The Pharma Data

OCTOBER 23, 2020

Remdesivir gets full FDA approval to treat COVID. Remdesivir’s full approval Thursday by the FDA comes after the agency granted it emergency use authorization last spring. It is given intravenously to hospitalized patients. Doctors say this reflects India’s younger and leaner population.

Hospitals 52

Hospitals Virus FDA Government 52

The Pharma Data

MAY 13, 2021

In this special report, I’m going to show you why researchers at Harvard University and the Massachusetts General Hospital in Boston are now praising a strange new pain treatment originally discovered on the International Space Station. WITHOUT doctors, physical therapists or chiropractors. And then got my Doctor of Pharmacy (Pharm.

Pharmacy 52

Pharmacy Doctors Production Therapies 52

The Pharma Data

JUNE 18, 2021

Undetectable minimal residual disease (uMRD) was achieved in 77% of patients in peripheral blood and 60% of patients in bone marrow. 2,3 CLL is predominately a disease of the elderly, with a median age at diagnosis of 70 years and is more common among men than women. IMBRUVICA is the only FDA-approved medicine in WM and cGVHD.

Treatment 40

Treatment FDA FDA Approval Therapies 40

The Pharma Data

JUNE 18, 2021

The study met its primary endpoint of superior progression-free survival (PFS) as assessed by an independent review committee (IRC) with a HR 0.216 (95% CI, 0.131-0.357; p < 0.0001), demonstrating a reduction in the risk of disease progression or death for I+V of approximately 78% compared to C+O. . About the GLOW Study.

Treatment 52

Treatment Therapies FDA FDA Approval 52

The Pharma Data

JUNE 18, 2021

“The results add to the extensive clinical evidence supporting the use of single-agent ibrutinib for long-term disease control.” IMBRUVICA ® is now approved in 101 countries and has been used to treat more than 230,000 patients worldwide across its approved indications. Barr , M.D., 1 Additionally, at 6.5

FDA Approval 40

FDA Approval Treatment FDA Therapies 40

The Pharma Data

OCTOBER 27, 2020

27, 2020 — Testing of Eli Lilly’s antibody drug for hospitalized COVID-19 patients has been halted because the treatment doesn’t help them recover from their infection. Hospitals feel the strain of surging COVID case counts. In Utah, hospital administrators have warned Gov. TUESDAY, Oct. But the U.S.

Trials 52

Trials Hospitals Drugs FDA 52

The Pharma Data

MAY 4, 2021

Rare Disease. Pfizer’s Meridian subsidiary, the manufacturer of EpiPen and other auto-injector products, which had been reported within the results of the Upjohn Business (4) in the first three quarters of 2020 , is now included within the Hospital therapeutic area for all periods presented. 1,611. . *. *. Internal Medicine.

Vaccine 40

Vaccine Production FDA Clinical Trials 40

The Pharma Data

NOVEMBER 23, 2020

The FDA has sanctioned the use of the Regeneron Pharmaceuticals Inc. drug to try to prevent hospitalization and worsening disease in patients with mild-to-moderate symptoms. Centers for Disease Control and Prevention asked Americans not to travel for Thanksgiving. The drug is given intravenously as a one-time treatment.

FDA Approval 52

FDA Approval Vaccine FDA Treatment 52

Drug & Device Law

OCTOBER 10, 2022

The drug at issue was an FDA-recognized breakthrough drug that treats a relatively rare, but invariably fatal, condition – transthyretin amyloid cardiomyopathy (“ATTR-CM”). ATTR-CM is a progressive heart disease that causes protein fibrils to deposit in the left ventricle of the heart, eventually leading to heart failure.

Drugs 52

Drugs FDA Approval FDA Disease 52